What does CUSIP 74587V107 represent in this 13F holders report?

CUSIP 74587V107 is the security identifier for PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in Q4 2015?

131 institutional investors reported PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock for Q4 2015. Use the holders table for investor-level position and value details.

PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)

CUSIP: 74587V107

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class: Equity / Common Stock
Shares outstanding: 49,633,071
Total 13F shares: 32,269,617
Share change: +2,193,934
Total reported value: $2,529,775,949
Put/Call ratio: 45%
Price per share: $78.40
Number of holders: 131
Value change: +$177,573,758
Number of buys: 54
Number of sells: 105

Quarterly Holders Quick Answers

What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2016
Previous quarter: Q3 2015

Recent filing periods for CUSIP 74587V107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	11%	5,686,668	$428,527,000	—	30 Sep 2015	13F
FMR LLC	13F	Company	9.8%	4,846,573	$365,238,000	—	30 Sep 2015	13F
VANGUARD GROUP INC	13F	Company	3.6%	1,774,973	$133,762,000	—	30 Sep 2015	13F
Capital Research Global Investors	13F	Company	3.5%	1,760,840	$132,697,000	—	30 Sep 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.5%	1,730,703	$130,426,000	—	30 Sep 2015	13F
Grantham, Mayo, Van Otterloo & Co. LLC	13F	Company	3.4%	1,676,678	$126,354,000	—	30 Sep 2015	13F
ORBIMED ADVISORS LLC	13F	Company	2.4%	1,195,500	$90,093,000	—	30 Sep 2015	13F
FRANKLIN RESOURCES INC	13F	Company	1.9%	960,999	$72,421,000	—	30 Sep 2015	13F
STATE STREET CORP	13F	Company	1.4%	692,406	$52,192,000	—	30 Sep 2015	13F
Capital International Investors	13F	Company	1.3%	650,486	$49,021,000	—	30 Sep 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.2%	590,290	$44,484,000	—	30 Sep 2015	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	1.1%	562,665	$42,402,000	—	30 Sep 2015	13F
Point72 Asset Management, L.P.	13F	Company	1.1%	554,019	$41,751,000	—	30 Sep 2015	13F
BB BIOTECH AG	13F	Company	1.1%	521,991	$39,337,000	—	30 Sep 2015	13F
CORNERSTONE CAPITAL MANAGEMENT LLC	13F	Company	1%	495,145	$37,314,000	—	30 Sep 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.71%	354,508	$26,713,000	—	30 Sep 2015	13F
TOBAM	13F	Company	0.64%	318,384	$23,994,000	—	30 Sep 2015	13F
CAPITAL GUARDIAN TRUST CO	13F	Company	0.58%	289,470	$21,814,000	—	30 Sep 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.51%	252,382	$19,019,000	—	30 Sep 2015	13F
RUSSELL FRANK CO/	13F	Company	0.47%	235,533	$17,749,000	—	30 Sep 2015	13F
BlackRock Fund Advisors	13F	Company	0.46%	227,353	$17,133,000	—	30 Sep 2015	13F
WESTFIELD CAPITAL MANAGEMENT CO LP	13F	Company	0.45%	221,356	$16,681,000	—	30 Sep 2015	13F
NORGES BANK	13F	Company	0.42%	206,876	$15,590,000	—	30 Sep 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.38%	186,343	$14,043,000	—	30 Sep 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.35%	174,410	$13,143,000	—	30 Sep 2015	13F
UBS Group AG	13F	Company	0.33%	165,049	$12,438,000	—	30 Sep 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.33%	162,600	$12,254,000	—	30 Sep 2015	13F
CAPITAL INTERNATIONAL LTD /CA/	13F	Company	0.29%	145,697	$10,980,000	—	30 Sep 2015	13F
WEATHERBIE CAPITAL, LLC	13F	Company	0.28%	137,041	$10,327,000	—	30 Sep 2015	13F
NORTHERN TRUST CORP	13F	Company	0.26%	130,876	$9,863,000	—	30 Sep 2015	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.25%	124,640	$9,393,000	—	30 Sep 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.25%	121,780	$9,170,000	—	30 Sep 2015	13F
Bank of New York Mellon Corp	13F	Company	0.24%	116,662	$8,792,000	—	30 Sep 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.23%	115,846	$8,730,000	—	30 Sep 2015	13F
Capital International Sarl	13F	Company	0.22%	109,405	$8,245,000	—	30 Sep 2015	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.2%	101,149	$7,623,000	—	30 Sep 2015	13F
Tekla Capital Management LLC	13F	Company	0.19%	95,200	$7,174,000	—	30 Sep 2015	13F
BlackRock Group LTD	13F	Company	0.19%	94,644	$7,131,000	—	30 Sep 2015	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.19%	92,632	$6,981,000	—	30 Sep 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	90,439	$6,815,000	—	30 Sep 2015	13F
Capital International, Inc./CA/	13F	Company	0.17%	85,450	$6,440,000	—	30 Sep 2015	13F
LMCG INVESTMENTS, LLC	13F	Company	0.17%	84,397	$6,361,000	—	30 Sep 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.16%	81,301	$6,127,000	—	30 Sep 2015	13F
Asset Management One Co., Ltd.	13F	Company	0.17%	83,434	$5,964,000	—	30 Sep 2015	13F
D. E. Shaw & Co., Inc.	13F	Company	0.15%	76,032	$5,730,000	—	30 Sep 2015	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.14%	71,873	$5,416,000	—	30 Sep 2015	13F
TEACHERS ADVISORS, LLC	13F	Company	0.14%	68,113	$5,133,000	—	30 Sep 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.14%	67,880	$5,115,000	—	30 Sep 2015	13F
CREDIT SUISSE AG/	13F	Company	0.12%	60,570	$4,565,000	—	30 Sep 2015	13F
S.c.a. Candriam	13F	Individual	0.12%	60,300	$4,544,000	—	30 Sep 2015	13F

Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2015

As of 31 Dec 2015, PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,269,617 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP LLC, FMR LLC, Grantham, Mayo, Van Otterloo & Co. LLC, ORBIMED ADVISORS LLC, Capital Research Global Investors, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., and STATE STREET CORP. This page lists 131 institutional shareholders reporting positions in this security for the Q4 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2015 vs Q3 2015 Across Filers

Q3 2015 holders

159

Q4 2015 holders

131

Holder diff

-28

Investor	Q3 2015 Shares	Q4 2015 Shares	Share Diff	Share Chg %	Q3 2015 Value $	Q4 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.